Abbott and Domantis Collaborate on Antibody Therapeutics

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)

Published: 2 Nov-2002

DOI: 10.3833/pdr.v2002.i30.974     ISSN: 1756-7874

Section: Research & Development



Abbott Laboratories signed a research and technology deal with Domantis Ltd, the second major deal of Domantis, to discover novel therapeutic products using Domantis’ domain antibody technology...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details